These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clinical inquiries: can recombinant growth hormone effectively treat idiopathic short stature?
    Author: Von Fange T, McDiarmid T, Mackler L, Zolotor A.
    Journal: J Fam Pract; 2008 Sep; 57(9):611-2. PubMed ID: 18786336.
    Abstract:
    Yes, treatment can increase a child's final height. Injections of recombinant human growth hormone (rGH) at least 3 times a week for 4 to 6 years add 3.7 to 7.5 cm to final height in children between 8 and 16 years of age with idiopathic short stature (strength of recommendation [SOR]: 2 small, low-quality, randomized controlled trials [RCTs]). This population comprises children who are otherwise physically and developmentally normal with a height standard deviation score (SDS) of <or=-2.0--comparable to the bottom 2.5% percentile of height--and an adequate response to growth hormone stimulation testing.
    [Abstract] [Full Text] [Related] [New Search]